Tasso Receives CE Mark Certification for Tasso+™, Latest Generation Whole Blood Collection Lancet Device
SEATTLE–(BUSINESS WIRE)–Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a convenient, virtually pain-free blood lancet that collects whole liquid blood samples. The CE Mark designation allows... Read More →
InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system
InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system. The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease. Read More
CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies
REHOVOT, Israel, Sept. 18, 2023 /PRNewswire/ — CardiaCare, a medical device company developing a breakthrough wearable technology for detecting, monitoring, and non-invasively treating cardiac arrhythmias using drug-free neuromodulation, recently closed an over-subscribed Seed Extension round. The financing was led by... Read More →
Conavi Medical Announces Close of Financing to Bolster Novel Intravascular Imaging Technology
TORONTO, CA, September 18, 2023 – Conavi Medical, Inc. (www.conavi.com), a leader in hybrid intravascular imaging, is pleased to announce the close of $12.5 mil USD of funding, including participation from existing investors. The round was led by CPOINT Capital,... Read More →
SpineGuide Technologies Receives U.S. FDA Breakthrough Device Designation for CurvRITE System in Treating Patients with EOS
St Paul, Minnesota, September 11, 2023 —- SpineGuide Technologies, a global medical device company, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its CurvRITE System to treat Children with Early Onset Scoliosis (EOS). The... Read More →
FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI
The basis for the approval was the successful results for deep-vein arterialization borne out in the PROMISE II trial. The US Food and Drug Administration has approved the LimFlow self-expanding covered stent system for arterialization of deep veins in the... Read More →
Sparta Biomedical Closes an Oversubscribed Convertible Round to Advance its Breakthrough Device
MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ — Sparta Biomedical Inc., a privately held medical technology company, revolutionizing osteoarthritis treatment, is pleased to announce the close of a heavily oversubscribed convertible funding round. The company is thrilled to welcome new medtech... Read More →
Morgantown-based Intermed Labs leverages AI and 3D printing to make prosthetics accessible featuring Fingy3D
MORGANTOWN — Retired coal miner Mark Lance was working with his son at his farm, cutting branches that were overhanging the house. Lance was the ground man holding the rope while his son cut the branches. “A branch came down,... Read More →
Sparta Biomedical’s Breakthrough Device, Ormi, to be Featured at the 17th ICRS World Congress on September 10, 2023
MORRISVILLE, N.C., Sept. 8, 2023 /PRNewswire/ — Sparta Biomedical, a privately held medical device company specializing in partial knee resurfacing, is excited to announce Dr. Adam Yanke’s presentation at the 2023 ICRS World Congress in Barcelona, Spain. Dr. Yanke is... Read More →
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
Thuja Capital and founding investor Sofinnova Partners also joined the round The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based catheter for the treatment of pulmonary hypertension, with initial focus on the... Read More →